Bioverativ Inc. is an American multinational biotechnology company that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia. Bioverativ competes with Baxalta, Pfizer and Novo Nordisk. From Wikipedia
Securing Ayvakit licensing reinforces Sanofi’s bid to dominate immunology with a focus on rare diseases
